Skip to main content
. 2020 Mar 30;102(6):1323–1327. doi: 10.4269/ajtmh.19-0691

Table 1.

Clinical and demographic characteristics of study participants

Characteristic Total ACL Non-ACL P-value
Number of subjects, n (%) 63 47 (74.6) 16 (25.4)
Gender, n (%)
 Male 51 (81.0) 41 (87.2) 10 (62.5) 0.059*
 Female 12 (19.0) 6 (12.8) 6 (37.5)
Age in years, median (range) 26 (3–70) 26 (3–57) 25.5 (5–70) 0.538†
Ethnicity, n (%)
 Afro-Colombian 28 (44.4) 21 (44.7) 7 (43.8)
 Mestizo 28 (44.4) 20 (42.6) 8 (50.0) 0.999*
 Indigenous 6 (9.5) 5 (10.6) 1 (6.2)
 Caucasian 1(1.6) 1 (2.1) 0
Time from onset of lesions in months, median (range) 2 (0.2–240) 1 (0.5–12) 3 (0.2–240) 0.063†
Number of lesions, median (IQR) 1 (1–12) 1 (1–6) 2 (1–12) 0.566†
CL Diagnostic method, n (%)
 Positive culture and smear NA 33 (70.2) NA
 Positive smear only 9 (19.2)
 Positive culture only 5 (10.6)
Leishmania strain isolated
Leishmania (Viannia) panamensis NA 31 (81.6) NA
Leishmania (Viannia) braziliensis 5 (13.2)
 Unavailable 2 (5.2)

ACL = American cutaneous leishmaniasis; IQR = interquartile range.

* Chi-squared test/Fisher’s test.

t-test/Wilcoxon rank sum test.